Navigation Links
Baron & Budd Attorney Denyse Clancy Speaks at International Mesothelioma Program's First Annual Harvard Medical School Course

DALLAS, July 7 /PRNewswire/ -- Denyse Clancy, an attorney and shareholder with the Dallas-based law firm Baron & Budd, P.C., spoke at the International Mesothelioma Program's First Annual Harvard Medical School Course, entitled Surgery-Based Multimodality Therapy for Malignant Pleural Mesothelioma. The program was held in Dallas on June 13 and 14.

The program was designed to update thoracic surgeons and other medical professionals about current diagnostic criteria and treatment options available for patients with pleural mesothelioma, a rare, asbestos-related cancer that attacks the lung's lining. It was co-sponsored by the American Association for Thoracic Surgery.

Ms. Clancy spoke with the group of medical professionals about how medical research articles are understood and applied in the courtroom -- sometimes in ways not intended by the scientist authors. Her words provoked lively discussion among the doctors and research scientists present, including questions about the scientific community's responsibility to anticipate the legal applications of their words.

Baron & Budd has a long-standing relationship with the International Mesothelioma Program (IMP). As a member of the IMP's Executive Advisory Board, the law firm is in regular contact with the IMP to remain abreast of mesothelioma research updates affecting treatment options. Baron & Budd was invited to become a member the Executive Board because of our experience and commitment to working with people with mesothelioma. Baron and Budd was the first and remains the longest-standing member of the IMP Executive Advisory Board.

About Baron & Budd, P.C.

Since 1977, the law firm of Baron & Budd, P.C. has championed the rights of people and communities harmed by corporate misconduct. With 49 attorneys and offices in Texas, California and Louisiana, Baron & Budd enjoys a national reputation as a leader of the plaintiffs' bar. The firm represents individuals with mesothelioma and other diseases caused by asbestos; leukemia caused by benzene; injuries caused by other toxic substances and unsafe pharmaceuticals; water authorities seeking clean-up costs for drinking water contamination; securities investors defrauded by corporate wrongdoing; and consumers in class actions.

Susan Knape, 1-244-521-3605

SOURCE Baron & Budd, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd
2. Former Texas Assistant Attorney General Pat OConnell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice
3. Baron & Budd, P.C., Announces $3.6 Million Settlement in California Asbestos Lawsuit
4. California Attorney Robert A. Brenner Launches The Burn Injury Law Group to Aid Burn Victims Nationwide
5. Blue Cross Blue Shield of Michigan Responds to Attorney Generals Complaint, Says Transaction Was Legal and Fully Authorized
6. L.A. City Attorney Rocky Delgadillo, Patient Activists to Unveil New Television Ad Targeting Health Insurers
7. Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Departments Efforts to Combat Healthcare Fraud Nationwide
8. Attorney General Michael B. Mukasey to Deliver Keynote Address at Naturalization Ceremony and Remarks on Nationwide Efforts to Combat Healthcare Fraud
9. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
10. Pennsylvania Attorney General Corbett Announces a Multi-state, $58 Million Settlement With Merck Over Deceptive Advertising Concerning the Safety of Vioxx
11. Wage Complaint Forwarded to Attorney General for Prosecution
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology: